Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease (ALZ)

This study has been completed.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00478491
First received: May 22, 2007
Last updated: October 25, 2016
Last verified: October 2016